at4x.png){kind=logo}
AscellaHealth Showcases End-to-End Specialty Pharmaceutical Commercialisation Solutions at World Orphan Drug Congress, Shapes Future of Rare and Orphan Disease Therapies | Business Wire AscellaHealth Showcases End-to-End Specialty Pharmaceutical Commercialisation Solutions at World Orphan Drug Congress, Shapes Future of Rare and Orphan Disease TherapiesOctober 02, 2024 06:00 AM Eastern Daylight Time DUBLIN--(BUSINESS WIRE)--AscellaHealth, a global partner delivering customisable solutions for the
.png)
AscellaHealth Podcast Pulse: AscellaHealth Launches Podcast Series Addressing Key Issues Impacting Life Sciences & Payers within the Specialty Healthcare Ecosystem | Business Wire Berwyn,?PA?– September 17, 2024 – AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, announces the launch of its podcast; AscellaHealth Podcast Pulse. This diverse new series dives deep into key topics shaping the future of global life sciences and healthcare
https://www.businesswire.com/news/home/20240912266129/en/AscellaHealth-Expands-Global-Leadership-Team-Specialty-Pharmaceutical-Experts-with-Manufacturer-and-Payer-Expertise-Propel-International-Growth Berwyn, PA and DUBLIN – September 12, 2024 – AscellaHealth,a global partner delivering customizable solutions to support the specialty pharmaceutical industry, announces the expansion of its executive team with the addition of seasoned professionals who have extensive international experience with life
at4x.png){kind=logo}
https://www.businesswire.com/news/home/20240910130887/en/AscellaHealth-Announces-Expansion-of-Optime-Care-Specialty-Pharmacy-Launches-Additional-Location-at-PA-Headquarters-to-Support-Operational-Growth Berwyn, PA and ST. LOUIS, MO – September 10, 2024 – AscellaHealth,a global partner delivering customizable solutions to support the specialty pharmaceutical industry, proudly announces the expansion of St. Louis, MO-based Optime Care, its nationally recognized specialty pharmacy, drug distribution and
at4x.png){kind=logo}
For the Fourth Time, AscellaHealth Makes the Inc. 5000, at No. 609 in 2024, With Three-Year Revenue Growth of 746.1 PercentFor the Fourth Time, AscellaHealth Makes the Inc. 5000, at No. 609 in 2024, With Three-Year Revenue Growth of 746.1 Percent | Business WireNEW YORK, August 13, 2024 – Inc. revealed today that AscellaHealth ranks No. 609 on the 2024 Inc. 5000, its annual list of the fastest-growing private companies in America. The prestigious ranking provides a data-driven look at the most successful
